However, the effects of captopril, reducing Ang II, decreasing parasitemia and protecting against experimental CM (Silva-Filho et al., 2013), apparently do not agree with the hypothesis that increased Ang II provides protection against severe malaria. The gene discussed is AGT; the disease is parasitic infectious disease.